Chemours
Mid Cap · Basic Materials · Specialty Chemicals
$15.42−$0.30 (-1.91%)
Chemours
Mid Cap · Basic Materials · Specialty Chemicals
$15.42−$0.30 (-1.91%)
Stock analysis
Get the AI take on CC
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$10.44
High$28.67
Today $15.42
RSI (14)
35.6Neutral
03070100
Overall score
52/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$15
Current price
$15.42
Median target
$18
Highest
$24
LowHigh
Operating Record
Revenue
What's working
- Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
- Price / sales: You're paying a modest amount for each dollar of revenue coming in.
What to watch
- Debt exceeds cash by $3.5B, increasing balance-sheet pressure, a warning sign.
- ROIC: Capital plowed back into the business isn't earning much for its trouble.
What the market charges
Forward P/E
Favorable · 38% below avg
10.48x
Price / sales
Strong · Priced modestly against the revenue it brings in
0.41x
Price / FCF
Strong · Priced well within what its cash flow supports
10.94x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
12.03x
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
3.6%
ROE
Needs attention · Unfavorable
-319.4%
Debt / equity
Needs attention · Unfavorable
-
Current ratio
Strong · Comfortable room to cover bills due within a year
1.66x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $2.39B | - | -0.9% | 52 |
 | $124.08B | 14.9 | +25.2% | 83 |
 | $12.34B | 23.6 | +89.8% | 81 |
 | $4.62B | 8.1 | +9.7% | 76 |
 | $95.48B | 32.8 | +0.2% | 70 |